CryoLife Inc. completed its previously announced acquisition of JOTEC AG.
In October, the company said it will acquire JOTEC for an up-front payment of $225 million.
JOTEC is a developer of technologically differentiated endovascular stent grafts and cardiac and vascular surgical grafts, focused on heart repair.
